Kaija Pyykkö

1.1k total citations
32 papers, 865 citations indexed

About

Kaija Pyykkö is a scholar working on Pharmacology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Kaija Pyykkö has authored 32 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Biology and 5 papers in Obstetrics and Gynecology. Recurrent topics in Kaija Pyykkö's work include Pharmacogenetics and Drug Metabolism (10 papers), Estrogen and related hormone effects (5 papers) and Pregnancy and preeclampsia studies (4 papers). Kaija Pyykkö is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Estrogen and related hormone effects (5 papers) and Pregnancy and preeclampsia studies (4 papers). Kaija Pyykkö collaborates with scholars based in Finland, United Kingdom and Japan. Kaija Pyykkö's co-authors include Risto Tuimala, Jukka Uotila, Markku Ahotupa, Seppo Kaukinen, Mika Scheinin, Risto Huupponen, Jouni Vuorinen, Jaana Kallio, Ullamari Pesonen and Markku Koulu and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and British Journal of Pharmacology.

In The Last Decade

Kaija Pyykkö

32 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaija Pyykkö Finland 16 262 224 138 108 108 32 865
Virginia Fernández Chile 22 144 0.5× 171 0.8× 46 0.3× 416 3.9× 111 1.0× 43 1.6k
M. Ruprah United Kingdom 14 42 0.2× 267 1.2× 113 0.8× 56 0.5× 128 1.2× 24 909
Shima Tavallaie Iran 22 112 0.4× 110 0.5× 51 0.4× 475 4.4× 151 1.4× 90 1.7k
Lucie Stejskalová Czechia 9 71 0.3× 108 0.5× 201 1.5× 313 2.9× 69 0.6× 11 947
P. Arvela Finland 17 39 0.1× 197 0.9× 276 2.0× 121 1.1× 89 0.8× 49 826
Bartolomé Bonet Spain 24 479 1.8× 475 2.1× 23 0.2× 187 1.7× 97 0.9× 41 1.4k
Henry Asare‐Anane Ghana 17 119 0.5× 239 1.1× 50 0.4× 329 3.0× 68 0.6× 41 1.1k
Sid Ahmed Merzouk Algeria 17 218 0.8× 274 1.2× 19 0.1× 118 1.1× 75 0.7× 38 912
Douglas C. Kuhn United States 18 139 0.5× 149 0.7× 46 0.3× 240 2.2× 92 0.9× 33 1.2k
P d'Athis France 17 38 0.1× 284 1.3× 79 0.6× 97 0.9× 75 0.7× 48 752

Countries citing papers authored by Kaija Pyykkö

Since Specialization
Citations

This map shows the geographic impact of Kaija Pyykkö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaija Pyykkö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaija Pyykkö more than expected).

Fields of papers citing papers by Kaija Pyykkö

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaija Pyykkö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaija Pyykkö. The network helps show where Kaija Pyykkö may publish in the future.

Co-authorship network of co-authors of Kaija Pyykkö

This figure shows the co-authorship network connecting the top 25 collaborators of Kaija Pyykkö. A scholar is included among the top collaborators of Kaija Pyykkö based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaija Pyykkö. Kaija Pyykkö is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vuori, Marja‐Liisa, et al.. (2001). Plasma Concentration of Topically Applied Betaxolol in Elderly Glaucoma Patients. Journal of Ocular Pharmacology and Therapeutics. 17(3). 207–213. 5 indexed citations
2.
Kallio, Jaana, et al.. (2000). Influence of hydroxychloroquine on the bioavailability of oral metoprolol. British Journal of Clinical Pharmacology. 49(6). 549–554. 82 indexed citations
3.
Sjöholm, Birgitta, et al.. (1999). Non‐adrenergic binding of [3H]atipamezole in rat kidney–regional distribution and comparison to α2‐adrenoceptors. British Journal of Pharmacology. 128(6). 1215–1222. 9 indexed citations
4.
Bitsios, Panos, R. W. Langley, Kaija Pyykkö, et al.. (1998). Comparison of the effects of moclobemide and selegiline on tyramine‐evoked mydriasis in man. British Journal of Clinical Pharmacology. 45(6). 551–558. 10 indexed citations
5.
Heinonen, Esa, Markku Anttila, Leena Nyman, et al.. (1997). Desmethylselegiline, a Metabolite of Selegiline, Is an Irreversible Inhibitor of Monoamine Oxidase Type B in Humans. The Journal of Clinical Pharmacology. 37(7). 602–609. 22 indexed citations
6.
Heinonen, Esa, Markku Anttila, Leena Nyman, et al.. (1997). Inhibition of Platelet Monoamine Oxidase Type B by Selegiline. The Journal of Clinical Pharmacology. 37(7). 597–601. 7 indexed citations
7.
Pyykkö, Kaija, et al.. (1994). Aryl hydrocarbon hydroxylase activity in chemically induced and toremifene‐treated mammary tumors in rats. International Journal of Cancer. 56(1). 140–145. 1 indexed citations
8.
Uotila, Jukka, et al.. (1993). Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. BJOG An International Journal of Obstetrics & Gynaecology. 100(3). 270–276. 149 indexed citations
9.
Uotila, Jukka, et al.. (1993). Pregnancy-Induced Hypertension Is Associated with Changes in Maternal and Umbilical Blood Antioxidants. Gynecologic and Obstetric Investigation. 36(3). 153–157. 39 indexed citations
10.
Huupponen, Risto, Kaija Pyykkö, Markku Koulu, & Juha Rouru. (1993). Metformin and liver glycogen synthase activity in obese Zucker rats.. PubMed. 79(2). 219–27. 2 indexed citations
11.
Pyykkö, Kaija, et al.. (1993). Cytochrome P450IA1 activity in human myometrium and uterine leiomyoma: Influence of smoking. Toxicology. 83(1-3). 41–48. 2 indexed citations
12.
Pyykkö, Kaija, et al.. (1992). The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non‐pregnant women.. British Journal of Clinical Pharmacology. 33(6). 629–633. 17 indexed citations
13.
Uotila, Jukka, et al.. (1991). Lipid peroxidation products, selenium-dependent glutathione peroxidase and vitamin E in normal pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 42(2). 95–100. 95 indexed citations
14.
Pyykkö, Kaija, et al.. (1991). Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer?. British Journal of Cancer. 63(4). 596–600. 25 indexed citations
15.
Kallio, Johanna, Risto Huupponen, & Kaija Pyykkö. (1990). The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide. European Journal of Clinical Pharmacology. 39(1). 93–95. 1 indexed citations
16.
Uotila, Jukka, Risto Tuimala, & Kaija Pyykkö. (1990). Erythrocyte Glutathione Peroxidase Activity in Hypertensive Complications of Pregnancy. Gynecologic and Obstetric Investigation. 29(4). 259–262. 26 indexed citations
17.
Pyykkö, Kaija, et al.. (1988). Effect of selenium supplementation to fertilizers on the selenium status of the population in different parts of Finland.. PubMed. 42(7). 571–9. 10 indexed citations
18.
Punnonen, R., Harri Jokela, R. Kudo, et al.. (1987). Serum lipids in Finnish and Japanese postmenopausal women. Atherosclerosis. 68(3). 241–247. 8 indexed citations
19.
Pyykkö, Kaija, Sari Paavilainen, T. Metsä‐Ketelä, & K. Laustiola. (1987). The Increasing and Decreasing Effects of Aromatic Hydrocarbon Solvents on Pulmonary and Hepatic Cytochrome P‐450 in the Rat. Pharmacology & Toxicology. 60(4). 288–293. 29 indexed citations
20.
Heinonen, Pentti K., Risto Tuimala, Kaija Pyykkö, & P Pystynen. (1982). Peripheral venous concentrations of oestrogens in postmenopausal women with ovarian cancer. BJOG An International Journal of Obstetrics & Gynaecology. 89(1). 84–86. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026